US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment

At 90 And Counting, Will Supplement Warnings Merit Mention In Response?

House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.

Test result of a Corona test. Hand turns a dice and changes the expression "positive COVID19" to "negative COVID19".

US House appropriators don’t mention the consumer health market in requesting a report on the Food and Drug Administration’s response to the COVID-19 pandemic, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning in its report.

Encouraging accelerated product of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

Innovations In US Hemp Market, Like States’ Regulatory Interest, More Than Skin Deep

 

Market growth and product innovations are continuing as FDA looks to Congress for authorization to establish regulatory pathway agency says it needs to determine whether to allow hemp-derived ingredients in food, dietary supplements and non-drug topicals including cosmetics.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By 

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Senators’ Questions Stray Far From OMUFA During HELP Committee Hearing On Reauthorization

 

HELP members state frustration with layoffs at FDA and pose questions about topics from generic drug approvals to OTC switches, and from manufacturing location labeling to whether the federal agencies intrude on US consumers. Still, acting CDER director Jacqueline Corrigan-Curay makes clear the resu

More from Policy & Regulation